Page 2 - Structural Proteins News Today

The Increasing government investments and R&D expenditure in pharmaceutical & biotechnology companies, growing industry-academia collaborations, and the patent expiry of biologics are the major factors driving the growth of the market. In 2020, the growth factors & chemokines segment accounted for the largest share of the market and is also expected to grow at the highest CAGR during the forecast period. Based on product, the recombinant proteins market is classified into growth factors and che...

Recombinant Proteins Market worth $1.7 billion by 2026 - Exclusive Report by MarketsandMarkets "Recombinant Proteins Market by Product (Growth Factors, Chemokines, Structural Proteins, Membrane Proteins), Application (Drug Discovery & Development, Academic Research), End User (Biotechnology Companies, CROs) - Global Forecast to 2026", published by MarketsandMarkets, the global Recombinant Proteins Market is projected to reach USD 1.7 billion by 2026 from USD 1.0 billion in 2021, at a CAGR of 9...